Development of New Drugs for Autoimmune Hemolytic Anemia
Pharmaceutics, 2022 Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by the autoantibody-mediated destruction of red blood cells, and treatments for it still remain challenging.
Zhengrui Xiao, Irina Murakhovskaya
doaj +2 more sources
Cold versus warm autoimmune hemolytic anemia in diffuse large B cell lymphoma: pathogenic and therapeutic implications: a case series [PDF]
Journal of Medical Case ReportsBackground Autoimmune hemolytic anemia-associated diffuse large B cell lymphoma is rare, with distinct pathogenic mechanisms and therapeutic responses in cold agglutinin syndrome (CAS) and warm autoimmune hemolytic anemia subtypes poorly characterized ...
Zhiye Zhang +3 more
doaj +2 more sources
Atypical autoimmune hemolytic anemia
Haematologica, 2011 9/L (10-90), bilirubin 1.5 mg/dL (0-1.0), lactate dehydrogenase 1715 U/L (normal < 210) and ferritin 697 ng/mL. The blood film showed microcytosis and coarse basophilic stippling consistent with β-thalassemia trait. Only very occasional spherocytes were noted and there was no agglutination.
David Telio +4 more
doaj +3 more sources
Refractory cold autoimmune hemolytic anemia as initial presentation of gastric B cell lymphoma: a case report [PDF]
Journal of Medical Case ReportsBackground Cold agglutinin disease is one of main two types of cold-antibody autoimmune hemolytic anemias, which can be either primary or, commonly, secondary to an infection or underlying lymphoproliferative disease [1].
Gayathri Fernando +4 more
doaj +2 more sources
Thymoma with Autoimmune Hemolytic Anemia
Case Reports in Oncology, 2014 A 38-year-old Japanese male was referred to our hospital with abnormal chest X-ray results and severe Coombs-positive hemolytic anemia. He was diagnosed with a stage IV, WHO type A thymoma and was treated with oral prednisolone (1 mg/kg/day) and ...
Kensuke Suzuki +4 more
doaj +3 more sources
Autoimmune hemolytic anemia [PDF]
Vnitřní lékařství, 2018 Autoimmune hemolytic anemia (AIHA) is caused by auto-antibodies directed against self red blood cell (RBC) surface antigens. A consequence may be an intravascular hemolysis mediated by activated complement or extravascular hemolysis caused by destruction of complex of RBC with autoantibody in spleen and liver.
Jaroslav, Čermák, Martin, Písačka
openaire +5 more sources
Pancytopenia with autoimmune hemolytic anemia
Apollo Medicine, 2021 Payal Bargujar +2 more
doaj +2 more sources
The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Frontiers in Immunology, 2023 Autoimmune hemolytic anemia (AIHA) is defined by increased erythrocyte turnover mediated by autoimmune mechanisms. While corticosteroids remain first-line therapy in most cases of warm-antibody AIHA, cold agglutinin disease is treated by targeting the ...
S. Berentsen, B. Fattizzo, W. Barcellini
semanticscholar +1 more source
Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps
Frontiers in Immunology, 2023 Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-antibodies, and has a variable clinical course ranging from fully compensated low grade hemolysis to severe life-threatening cases.
Femke V. M. Mulder +7 more
semanticscholar +1 more source
Acute Tubular Necrosis Associated with Autoimmune Hemolytic Anemia due to Acute Gastroenteritis
Turkish Journal of Internal Medicine, 2021 Autoimmune hemolytic anemia (AIHA) is a rare disease with a rate of 1-3 in 100,000 in adults. AIHA are defined as primary (idiopathic) or secondary depending on the presence or absence of accompanying disease.
Mehmet Sezen +7 more
doaj +1 more source